← Live StudiesRegistry: recruitingPhase 3

Enicepatide for obesity without type 2 diabetes

Compares once-weekly investigational enicepatide, at several doses, with placebo for weight management in adults with obesity, or overweight with a weight-related condition, who do not have type 2 diabetes.

Who it's for

  • Age 18+
  • BMI ≥30, or ≥27 with a weight-related condition
  • Diabetes excluded

Full eligibility rules apply. The study team decides who can take part.

Where it runs

6 research locations in Arizona, California, Hawaii and Utah.

Arizona

  • Arizona Clinical TrialsTucson, AZ

California

  • University of California IrvineIrvine, CA
  • Artemis Institute for Clinical Research, LLCSan Diego, CA
  • Diablo Clinical Research, Inc.Walnut Creek, CA

Hawaii

  • East-West Medical Research InstituteHonolulu, HI

Utah

  • George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, UT

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.